AD/HD News
ADHD News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

  • Actavis Receives FDA Approval Of Atomoxetine HCl Capsules
    Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention deficit/hyperactivity disorder (ADHD). Actavis intends to market Atomoxetine HCl in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg strengths...

  • Sun Pharma Announces USFDA Approval For Generic Strattera(R) Capsules
    Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules...

  • Cognitive Behavioral Therapy Appears Beneficial For Adults With ADHD
    Adults with attention-deficit/hyperactivity disorder (ADHD) who received medication and individual sessions of cognitive behavioral therapy (CBT) showed greater improvement in symptoms through 12 months compared to patients who did not receive CBT, according to a study in the August 25 issue of JAMA. "Approximately 4...

  • Cognitive Behavior Therapy Improves Symptom Control In Adult ADHD
    Adding cognitive behavioral therapy -- an approach that teaches skills for handling life challenges and revising negative thought patterns -- to pharmaceutical treatment for attention-deficit hyperactivity disorder (ADHD) significantly improved symptom control in a study of adult patients...

  • Cognitive Behavioral Therapy Plus Medication Better Than Medication Alone For ADHD Adult Patients
    An adult with attention-deficit/hyperactivity disorder (ADHD) who takes targeted medication combined with 1-on-1 sessions of CBT (cognitive behavioral therapy) is likely to experience significantly greater improvement of symptoms compared to an ADHD adult patient who only has the medication, according to research published in JAMA (Journal of the American Medical Association), August 25th issue...

  • New ADHD Study Shows The Potential Efficacy Of New Multi-Modal Hemispheric Based Program In Boosting Academic And Cognitive Performance Of Children
    A new ADD/ADHD study found that a multi-modal hemispheric based program significantly improved the participant's educational outcomes...

  • Curemark To Present At BioPharm America? 2010
    Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, will present at BioPharm America? 2010, to be held September 15-17 in Boston at the Marriott Boston Copley Place, the company announced. Dr. Joan Fallon, Curemark's founder and CEO, will provide an overview of the company's enzyme replacement therapy targeted to autism...

  • Pesticides May Be Contributing To ADHD And Adversely Affecting Brain Development
    A baby is more likely to suffer from ADHD (attention deficit/hyperactivity disorder) while it is still in the womb if the mother is exposed to organophosphate (OP) pesticides, according to a new study published in Environmental Health Perspectives. Over the last few years there has been increasing interest in determining whether OP pesticides might undermine brain development...

  • Prenatal Pesticide Exposures Linked To Attention Disorders In Preschool Children
    Exposure to organophosphate (OP) pesticides before birth can increase susceptibility to attention disorders such as attention deficit/hyperactivity disorder (ADHD), according to new research published in the journal Environmental Health Perspectives (EHP). The new study is part of a growing body of research indicating that exposure to OP pesticides can adversely affect brain development...

  • ADHD Could Be Misdiagnosed In Nearly 1 Million US Kids Say Researchers
    Two studies published recently suggest there could be something wrong with the way ADHD is diagnosed in young children in the US, one found that nearly 1 million kids are potentially misdiagnosed just because they are the youngest in their kindergarten year, with the youngest in class twice as likely to be on stimulant medication, while the other study confirmed that ...


[ Back ]